Success Metrics

Clinical Success Rate
100.0%

Based on 49 completed trials

Completion Rate
100%(49/49)
Active Trials
0(0%)
Results Posted
2%(1 trials)

Phase Distribution

Ph phase_2
18
32%
Ph phase_1
7
13%
Ph phase_3
13
23%
Ph phase_4
5
9%
Ph not_applicable
13
23%

Phase Distribution

7

Early Stage

18

Mid Stage

18

Late Stage

Phase Distribution56 total trials
Phase 1Safety & dosage
7(12.5%)
Phase 2Efficacy & side effects
18(32.1%)
Phase 3Large-scale testing
13(23.2%)
Phase 4Post-market surveillance
5(8.9%)
N/ANon-phased studies
13(23.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.1%

49 of 51 finished

Non-Completion Rate

3.9%

2 ended early

Currently Active

0

trials recruiting

Total Trials

56

all time

Status Distribution
Completed(49)
Terminated(2)
Other(5)

Detailed Status

Completed49
unknown4
Withdrawn2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
56
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (12.5%)
Phase 218 (32.1%)
Phase 313 (23.2%)
Phase 45 (8.9%)
N/A13 (23.2%)

Trials by Status

unknown47%
completed4988%
suspended12%
withdrawn24%

Recent Activity

Clinical Trials (56)

Showing 20 of 56 trialsScroll for more
NCT00000872Phase 2

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Completed
NCT00102960Phase 3

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Completed
NCT00011479Phase 1

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

Completed
NCT00004855Not Applicable

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Completed
NCT00001086Phase 2

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Completed
NCT00006152Phase 2

A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Completed
NCT00021489Phase 2

Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment

Withdrawn
NCT00102206Phase 2

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Completed
NCT00000940Phase 2

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Completed
NCT00000912Phase 2

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Completed
NCT00000864Phase 1

A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women

Completed
NCT00000865Phase 1

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Completed
NCT00000885Phase 2

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Completed
NCT00006617Not Applicable

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

Completed
NCT00006578Not Applicable

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Withdrawn
NCT00000922Not Applicable

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Completed
NCT00087945Not Applicable

Blood Levels of Abacavir in HIV Infected Adolescents

Completed
NCT00006154Phase 3

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Completed
NCT00028314Not Applicable

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Completed
NCT00000919Not Applicable

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Completed

Drug Details

Intervention Type
DRUG
Total Trials
56